Landscape Capital Management L.L.C. Takes Position in CVS Health Corporation $CVS

Landscape Capital Management L.L.C. bought a new position in CVS Health Corporation (NYSE:CVS) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 82,314 shares of the pharmacy operator’s stock, valued at approximately $8,515,000. CVS Health accounts for about 0.6% of Landscape Capital Management L.L.C.’s holdings, making the stock its 19th largest holding.

A number of other institutional investors have also bought and sold shares of CVS. Caitong International Asset Management Co. Ltd lifted its position in shares of CVS Health by 407.2% in the third quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock valued at $26,000 after acquiring an additional 281 shares in the last quarter. Swiss RE Ltd. purchased a new stake in shares of CVS Health during the fourth quarter worth about $26,000. Kilter Group LLC bought a new stake in CVS Health during the 2nd quarter valued at approximately $27,000. Sankala Group LLC purchased a new position in CVS Health in the 4th quarter worth approximately $28,000. Finally, Global Trust Asset Management LLC lifted its holdings in CVS Health by 344.8% in the 1st quarter. Global Trust Asset Management LLC now owns 387 shares of the pharmacy operator’s stock worth $28,000 after purchasing an additional 300 shares in the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Stock Down 0.7%

NYSE CVS opened at $93.01 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87. The company has a market capitalization of $118.96 billion, a P/E ratio of 24.61, a P/E/G ratio of 0.85 and a beta of 0.61. CVS Health Corporation has a one year low of $69.51 and a one year high of $110.68. The stock has a 50 day moving average price of $102.02 and a 200-day moving average price of $88.86.

CVS Health (NYSE:CVS) last posted its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, beating analysts’ consensus estimates of $1.87 by $0.71. The firm had revenue of $106.10 billion during the quarter, compared to analyst estimates of $100.03 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. CVS Health’s revenue for the quarter was up 7.3% compared to the same quarter last year. During the same period last year, the firm posted $1.81 earnings per share. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, equities analysts predict that CVS Health Corporation will post 8.02 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd were issued a $0.665 dividend. The ex-dividend date was Thursday, July 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.9%. CVS Health’s payout ratio is 70.37%.

Analysts Set New Price Targets

A number of brokerages have issued reports on CVS. HSBC reaffirmed a “hold” rating and set a $103.00 price objective on shares of CVS Health in a report on Monday, July 6th. Mizuho upped their target price on shares of CVS Health from $110.00 to $115.00 and gave the stock an “outperform” rating in a research report on Monday, June 8th. DA Davidson raised their target price on shares of CVS Health from $80.00 to $100.00 and gave the company a “buy” rating in a research note on Thursday, May 7th. Deutsche Bank Aktiengesellschaft lifted their price target on shares of CVS Health from $88.00 to $92.00 and gave the company a “buy” rating in a report on Thursday, May 7th. Finally, JPMorgan Chase & Co. increased their price objective on shares of CVS Health from $111.00 to $118.00 and gave the company an “overweight” rating in a report on Wednesday, August 12th. Twenty-two analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, CVS Health currently has a consensus rating of “Moderate Buy” and an average price target of $107.17.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.